Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO).


Journal

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 01 09 2021
accepted: 19 09 2021
pubmed: 18 11 2021
medline: 1 4 2022
entrez: 17 11 2021
Statut: ppublish

Résumé

The new Medical Licensing Regulations 2025 (Ärztliche Approbationsordnung, ÄApprO) will soon be passed by the Federal Council (Bundesrat) and will be implemented step by step by the individual faculties in the coming months. The further development of medical studies essentially involves an orientation from fact-based to competence-based learning and focuses on practical, longitudinal and interdisciplinary training. Radiation oncology and radiation therapy are important components of therapeutic oncology and are of great importance for public health, both clinically and epidemiologically, and therefore should be given appropriate attention in medical education. This report is based on a recent survey on the current state of radiation therapy teaching at university hospitals in Germany as well as the contents of the National Competence Based Learning Objectives Catalogue for Medicine 2.0 (Nationaler Kompetenzbasierter Lernzielkatalog Medizin 2.0, NKLM) and the closely related Subject Catalogue (Gegenstandskatalog, GK) of the Institute for Medical and Pharmaceutical Examination Questions (Institut für Medizinische und Pharmazeutische Prüfungsfragen, IMPP). The current recommendations of the German Society for Radiation Oncology (Deutsche Gesellschaft für Radioonkologie, DEGRO) regarding topics, scope and rationale for the establishment of radiation oncology teaching at the respective faculties are also included.

Identifiants

pubmed: 34786605
doi: 10.1007/s00066-021-01861-7
pii: 10.1007/s00066-021-01861-7
pmc: PMC8594460
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Informations de copyright

© 2021. The Author(s).

Références

Ochsner J. 2016 Spring;16(1):14-5
pubmed: 27026786
Strahlenther Onkol. 2020 Aug;196(8):699-704
pubmed: 32367455
Acad Med. 2013 Dec;88(12):1798-801
pubmed: 24128642
Med Teach. 2019 Oct;41(10):1124-1128
pubmed: 31215320
Strahlenther Onkol. 2019 Dec;195(12):1104-1109
pubmed: 31309265
BMC Med Educ. 2018 Dec 4;18(1):294
pubmed: 30514278
Med Teach. 2009 Jul;31(7):591-600
pubmed: 19811144
Acad Med. 2013 Oct;88(10):1407-10
pubmed: 23969367
Strahlenther Onkol. 2021 Jun;197(6):528-536
pubmed: 33230568

Auteurs

H Dapper (H)

Department of Radiation Oncology, Technical University of Munich, Munich, Germany. hendrik.dapper@mri.tum.de.
German Cancer Consortium (DKTK) Partner Site (DKTK), Munich, Germany. hendrik.dapper@mri.tum.de.

C Belka (C)

Department of Radiation Oncology, LMU University Hospital, Munich, Germany.
German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

F Bock (F)

Department of Radiation Oncology, Rostock University Medical Center, Rostock, Germany.

V Budach (V)

Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

W Budach (W)

Department of Radiation Oncology, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany.

H Christiansen (H)

Department of Radiation Oncology, Hannover Medical School (MHH), Hannover, Germany.

J Debus (J)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany.

L Distel (L)

Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany.

J Dunst (J)

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.

F Eckert (F)

Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
German Cancer Consortium (DKTK) Partner Site (DKTK), Tübingen, Germany.

H Eich (H)

Department of Radiation Oncology, University of Münster, Münster, Germany.

W Eicheler (W)

OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.

R Engenhart-Cabillic (R)

Department of Radiotherapy and Radiation Oncology, University of Marburg, Marburg, Germany.

R Fietkau (R)

Department of Radiation Oncology, University Hospital Erlangen, Erlangen, Germany.

D F Fleischmann (DF)

Department of Radiation Oncology, LMU University Hospital, Munich, Germany.
German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

B Frerker (B)

Department of Radiation Oncology, Rostock University Medical Center, Rostock, Germany.

F A Giordano (FA)

Department of Radiation Oncology, University Hospital Bonn, University of Bonn, Bonn, Germany.

A L Grosu (AL)

Department of Radiation Oncology, University Medical Center Freiburg, Freiburg, Germany.
German Cancer Consortium (DKTK) Partner Site (DKTK), Freiburg, Germany.

K Herfarth (K)

Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Heidelberg Ion-Beam Therapy Center, Heidelberg, Germany.

G Hildebrandt (G)

Department of Radiation Oncology, Rostock University Medical Center, Rostock, Germany.

D Kaul (D)

Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Partner Site Berlin, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

O Kölbl (O)

Department of Radiotherapy, University of Regensburg, Regensburg, Germany.

M Krause (M)

Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
Partner Site Dresden, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
Heidelberg and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Dresden, Germany.

D Krug (D)

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.

D Martin (D)

Department of Radiotherapy and Oncology, University Hospital, Goethe University, Frankfurt, Germany.
German Cancer Consortium (DKTK) Partner Site (DKTK), Frankfurt, Germany.

C Matuschek (C)

Department of Radiation Oncology, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany.

D Medenwald (D)

Deptartment of Radiation Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

N H Nicolay (NH)

Department of Radiation Oncology, University Medical Center Freiburg, Freiburg, Germany.
German Cancer Consortium (DKTK) Partner Site (DKTK), Freiburg, Germany.

M Niewald (M)

Department of Radiotherapy and Radiooncology, Saarland University Medical Center, Homburg, Germany.

M Oertel (M)

Department of Radiation Oncology, University of Münster, Münster, Germany.

C Petersen (C)

Department of Radiotherapy and Radio-Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

F Pohl (F)

Department of Radiotherapy, University of Regensburg, Regensburg, Germany.

A Raabe (A)

Department of Radiotherapy and Radio-Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

C Rödel (C)

Department of Radiotherapy and Oncology, University Hospital, Goethe University, Frankfurt, Germany.
German Cancer Consortium (DKTK) Partner Site (DKTK), Frankfurt, Germany.

C Rübe (C)

Department of Radiotherapy and Radiooncology, Saarland University Medical Center, Homburg, Germany.

C Schmalz (C)

Department of Radiation Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.

L C Schmeel (LC)

Department of Radiation Oncology, University Hospital Bonn, University of Bonn, Bonn, Germany.

D Steinmann (D)

Department of Radiation Oncology, Hannover Medical School (MHH), Hannover, Germany.

G Stüben (G)

Department of Radiation Oncology, University of Augsburg, Augsburg, Germany.

R Thamm (R)

Department of Radiation Oncology and Radiotherapy, University Hospital Ulm, Ulm, Germany.

D Vordermark (D)

Deptartment of Radiation Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

H Vorwerk (H)

Department of Radiotherapy and Radiation Oncology, University of Marburg, Marburg, Germany.

T Wiegel (T)

Department of Radiation Oncology and Radiotherapy, University Hospital Ulm, Ulm, Germany.

D Zips (D)

Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
German Cancer Consortium (DKTK) Partner Site (DKTK), Tübingen, Germany.

S E Combs (SE)

Department of Radiation Oncology, Technical University of Munich, Munich, Germany.
Institute of Radiation Medicine, Department of Radiation Sciences, Helmholtz Zentrum München, Munich, Germany.
German Cancer Consortium (DKTK) Partner Site (DKTK), Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH